Cell based therapy for duchenne muscular dystrophy

Journal of Cellular Physiology

Volumn 221, Issue 3, 2009, Pages 526-534

  Farini, Andrea ^a   Razini, Paola ^a   Erratico, Silvia ^a   Torrente, Yvan ^a   Meregalli, Mirella ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIBODY; DYSTROPHIN; MEMBRANE ANTIGEN; TACROLIMUS; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANTIGEN EXPRESSION; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL POPULATION; DUCHENNE MUSCULAR DYSTROPHY; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; MESOANGIOBLAST; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; PERICYTE; PRIORITY JOURNAL; SATELLITE CELL; SHORT SURVEY; STEM CELL; STEM CELL TRANSPLANTATION; ANIMAL; CYTOLOGY; GENE THERAPY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; REVIEW; SKELETAL MUSCLE SATELLITE CELL; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD; GENE THERAPY; GLYCOPROTEINS; HUMANS; MUSCULAR DYSTROPHY, DUCHENNE; PEPTIDES; PERICYTES; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 70449710932     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21895     Document Type: Short Survey

References (110)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilić J, Pekarik V, Tiscornia G, Edel M, Boué S, Belmonte JC. 2008. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-1284.
2. Alessandri G, Pagano S, Bez A, Benetti A, Pozzi S, Iannolo G, Baronio M, Invernici G, Caruso A, Muneretto C, Bisleri G, Parati E. 2004. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364:1872-1883. (Pubitemid 39536091)
3. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S. 2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321:699-702. Erratum in: Science 2008;321(5889):641.
4. Asakura A, Rudnicki MA. 2002. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp Hematol 30:1339-1345. (Pubitemid 35287588)
5. Aubert D, Ménoret S, Chiari E, Pichard V, Durand S, Tesson L, Moullier P, Anegon I, Ferry N. 2002. Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat. Mol Ther 5:388-396. (Pubitemid 34308663)
6. Benchaouir R, Meregalli M, Farini A, D'Antona G, Belicchi M, Goyenvalle A, Battistelli M, Bresolin N, Bottinelli R, Garcia L, Torrente Y. 2007. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 13:646-657. (Pubitemid 350225348)
7. Bertoni C. 2008. Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides. Front Biosci 13:517-527. (Pubitemid 351599762)
8. Biggar WD, Harris VA, Eliasoph L, Alman B. 2006. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 6:249-255.
9. Bridenbaugh S, Kenins L, Bouliong-Pillai E, Kalberer CP, Shklovskaya E, Gratwohl A, Wodnar-Filipowicz A. 2008. Clinical stem-cell sources contain CD8+CD3+ T-cell receptor-negative cells that facilitate bone marrow repopulation with hematopoietic stem cells. Blood 111:1735-1738. (Pubitemid 351213466)
10. Buckingham M. 2006. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev 16:525-532. (Pubitemid 44345205)
11. Caplan A. 2008. All MSCs are pericytes? Cell Stem Cell 3:229-230.
12. Cell Tissue Res 250(3):563-569.
13. Chargé SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238. (Pubitemid 38049880)
14. Conway SJ, Henderson DJ, Copp AJ. 1997. Pax3 is required for cardiac neural crest migration in the mouse: Evidence from the splotch (Sp2H) mutant. Development 124:505-514. (Pubitemid 27101684)
15. Cossu G, Bianco P. 2003. Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev 13:537-542. (Pubitemid 37204932)
16. Cossu G, Molinaro M. 1987. Cell heterogeneity in the myogenic lineage. Curr Top Dev Biol 23:185-208.
17. Cossu G, Sampaolesi M. 2007. New therapies for Duchenne muscular dystrophy: Challenges, prospects and clinical trials. Trends Mol Med 13:520-526. (Pubitemid 350130348)
18. Daston G, Lamar E, Olivier M, Goulding M. 1996. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development 122:1017-1027. (Pubitemid 26096005)
19. Davies KE, Grounds MD. 2006. Treating muscular dystrophy with stem cells? Cell 127:1304-1306.
20. Deasy BM, Jankowski RJ, Huard J. 2001. Muscle-derived stem cells: Characterization and potential for cell-mediated therapy. Blood Cells Mol Dis 27:924-933. (Pubitemid 33145039)
21. Deasy BM, Gharaibeh BM, Pollett JB, Jones MM, Lucas MA, Kanda Y, Huard J. 2005. Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell 16:3323-3333. (Pubitemid 40962601)
22. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L, Innocenzi A, Galvez BG, Messina G, Morosetti R, Li S, Belicchi M, Peretti G, Chamberlain JS, Wright WE, Torrente Y, Ferrari S, Bianco P, Cossu G. 2007. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9:255-267. (Pubitemid 46349927)
23. Denti MA, Rosa A, D'Antona G, Sthandier O, De Angelis FG, Nicoletti C, Allocca M, Pansarasa O, Parente V, Musarò A, Auricchio A, Bottinelli R, Bozzoni I. 2006. Chimeric adeno-associated virus/antisense U1 small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice. Hum Gene Ther 17:565-574. (Pubitemid 43794495)
24. Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, Takeda S, Ide C, Nabeshima Y. 2005. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309:314-317.
25. Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. 1998. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 13:28-38.
26. Emery AE. 2002. The muscular dystrophies. Lancet 359:687-695.
27. Faber-Langendoen K, Caplan AL, McGlave PB. 1993. Survival of adult bone marrow transplant patients receiving mechanical ventilation: A case for restricted use. Bone Marrow Transplant 12:501-507. (Pubitemid 23328365)
28. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530. Erratum in: Science 1998;281(5379):923.
29. Ferrari G, Stornaiuolo A, Mavilio F. 2001. Failure to correct murine muscular dystrophy. Nature 411:1014-1015. (Pubitemid 32612316)
30. Fletcher S, Honeyman K, Fall AM, Harding PL, Johnsen RD, Wilton SD. 2006. Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. J Gene Med 8:207-216. (Pubitemid 43250701)
31. Galvez BG, Sampaolesi M, Brunelli S, Covarello D, Gavina M, Rossi B, Constantin G, Torrente Y, Cossu G. 2006. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol 174:231-243. (Pubitemid 44079858)
32. Gavina M, Belicchi M, Rossi B, Ottoboni L, Colombo F, Meregalli M, Battistelli M, Forzenigo L, Biondetti P, Pisati F, Parolini D, Farini A, Issekutz AC, Bresolin N, Rustichelli F, Constantin G, Torrente Y. 2006. VCAM-1expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation. Blood 108:2857-2866. (Pubitemid 44777027)
33. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP. 1997. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3:1337-1345. (Pubitemid 28011033)
34. Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, Danos O. 2004. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306:1796-1799. (Pubitemid 39601401)
35. Grounds MD. 2008. Two-tiered hypotheses for Duchenne muscular dystrophy. Cell Mol Life Sci 65:1621-1625.
36. Grounds MD, McGeachie JK. 1987. A model of myogenesis in vivo, derived from detailed autoradiographic studies of regenerating skeletal muscle, challenges the concept of quantal mitosis. Cell Tissue Res 250:563-569.
37. Gussoni E, Pavlath GK, Lanctot AM, Sharma KR, Miller RG, Steinman L, Blau HM. 1992. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356:435-438.
38. Gussoni E, Blau HM, Kunkel LM. 1997. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3:970-976. (Pubitemid 27391950)
39. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-394. (Pubitemid 29454964)
40. Hamed SA. 2006. Drug evaluation: PTC-124-a potential treatment of cystic fibrosis and Duchenne muscular dystrophy. IDrugs 9:783-789.
41. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923.
42. Hoffman EP, Brown RH Jr, Kunkel LM. 1987. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928. (Pubitemid 18099471)
43. Horsley V, Jansen KM, Mills ST, Pavlath GK. 2003. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113:483-494. (Pubitemid 36588751)
44. Huard J, Roy R, Bouchard JP, Malouin F, Richards CL, Tremblay JP. 1992. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc 24:3049-3051. (Pubitemid 23011825)
45. Hyser CL, Mendell JR. 1988. Recent advances in Duchenne and Becker muscular dystrophy. Neurol Clin 6:429-453. (Pubitemid 18223393)
46. Jackson KA, Mi T, Goodell MA. 1999. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 96:14482-14486. (Pubitemid 30000676)
47. Jaenisch R, Young R. 2008. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:567-582. (Pubitemid 351253686)
48. Jiang H, Pierce GF, Ozelo MC, de Paula EV, Vargas JA, Smith P, Sommer J, Luk A, Manno CS, High KA, Arruda VR. 2006. Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B. Mol Ther 14:452-455. (Pubitemid 44184967)
49. Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC, Pavan WJ, Trent JM, Meltzer PS. 1999. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA 96:13264-13269.
50. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. 2001. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369-377. (Pubitemid 32455343)
51. LaBarge MA, Blau HM. 2002. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111:589-601.
52. Lamagna C, Bergers G. 2006. The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 80:677-678. (Pubitemid 44835880)
53. Law PK, Goodwin TG, Wang MG. 1988. Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve 11:525-533.
54. Law PK, Goodwin TG, Li HJ. 1998. Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice. Transplant Proc 20:1114-1119.
55. Lechner A, Leech CA, Abraham EJ, Nolan AL, Habener JF. 2002. Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter. Biochem Biophys Res Commun 293:670-674.
56. Lennon DP, Caplan AI. 2006. Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol 34:1604-1605.
57. Marshall E. 1999. Gene therapy death prompts review of adenovirus vector. Science 286:2244-2245.
58. Matsumura K, Ohlendieck K, Ionasescu VV, Tomé FM, Nonaka I, Burghes AH, Mora M, Kaplan JC, Fardeau M, Campbell KP. 1993. The role of the dystrophin-glycoprotein complex in the molecular pathogenesis of muscular dystrophies. Neuromuscul Disord 3:533-535.
59. McClorey G, Moulton HM, Iversen PL, Fletcher S, Wilton SD. 2006. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther 13:1373-1381.
60. McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavilio F, Goodell MA. 2002. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 99:1341-1346.
61. Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R. 1995. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Eng J Med 333:832-838.
62. Meregalli M, Farini A, Torrente Y. 2008. Combining stem cells and exon skipping strategy to treat muscular dystrophy. Expert Opin Biol Ther 8:1051-1061.
63. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. 2000. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779-1782. (Pubitemid 32004811)
64. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW. 1997. A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood 90:5013-5021. (Pubitemid 28007218)
65. Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, Cumano A, Partridge T, Buckingham M. 2005. Direct isolation of satellite cells for skeletal muscle regeneration. Science 309:2064-2067.
66. Morgan J, Muntoni F. 2007. Mural cells paint a new picture of muscle stem cells. Nat Cell Biol 9:249-251. (Pubitemid 46344603)
67. Morgan JE, Coulton GR, Partridge TA. 1987. Muscle precursor cells invade and repopulate freeze-killed skeletal muscles. J Muscle Res Cell Motil 8:386-396.
68. Morgan JE, Fletcher RM, Partridge TA. 1996. Yields of muscle from myogenic cells implanted into young and old mdx hosts. Muscle Nerve 19:132-139.
69. Motohashi N, Uezumi A, Yada E, Fukada S, Fukushima K, Imaizumi K, Miyagoe-Suzuki Y, Takeda S. 2008. Muscle CD31(-) CD45(+) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts. Am J Pathol 173:781-791.
70. Negroni E, Butler-Browne GS, Mouly V. 2006. Myogenic stem cells: Regeneration and cell therapy in human skeletal muscle. Pathol Biol 54:100-108.
71. Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317. (Pubitemid 47080336)
72. Owonikoko T, Agha M, Balassanian R, Smith R, Raptis A. 2007. Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant. Nat Clin Pract Oncol 4:491-495. (Pubitemid 47393805)
73. Parise G, O'Reilly CE, Rudnicki MA. 2006. Molecular regulation of myogenic progenitor populations. Appl Physiol Nutr Metab 31:773-781.
74. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. 1989. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337:176-179.
75. Péault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T, Gussoni E, Kunkel LM, Huard J. 2007. Stem and progenitor cells in skeletal muscle development,maintenance, and therapy. Mol Ther 15:867-877. (Pubitemid 46621645)
76. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147. (Pubitemid 29282067)
77. Price FD, Kuroda K, Rudnicki MA. 2007. Stem cell based therapies to treat muscular dystrophy. Biochim Biophys 1772:272-283.
78. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74. (Pubitemid 27161245)
79. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A. 2002. Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol 157:851-864. (Pubitemid 34847822)
80. Radley HG, Grounds MD. 2006. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice. Neurobiol Dis 23:387-397.
81. Ray PN, et al. 1985. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature 318:672-675. (Pubitemid 16172419)
82. Riviere C, Danos O, Douar AM. 2006. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adultmice. Gene Ther 13:1300-1308. (Pubitemid 44264084)
83. Roy R, Tremblay JP, Huard J, Richards C, Malouin F, Bouchard JP. 1993. Antibody formation after myoblast transplantation in Duchennedystrophic patients, donor HLA compatible. Transplant Proc 25:995-997.
84. Sampaolesi M, Blot S, D'Antona G, et al. 2006. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444:574-579.
85. Sarig R, Baruchi Z, Fuchs O, Nudel U, Yaffe D. 2006. Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem Cells 24:1769-1778.
86. Schor AM, Canfield AE, Sutton AB, Arciniegas E, Allen TD. 1995. Pericyte differentiation. Clin Orthop Relat Res 313:81-91.
87. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA. 2000. Pax7 is required for the specification of myogenic satellite cells. Cell 102:777-786.
88. Seale P, Ishibashi J, Scimé A, Rudnicki MA. 2004. Pax7 is necessary and sufficient for the myogenic specification of CD45+:Sca1+stem cells from injured muscle. PLoS Biol 2:E130.
89. Sherman W. 2007. Myocyte replacement therapy: Skeletal myoblasts. Cell Transplant 16:971-975.
90. Singh N, Pillay V, Choonara YE. 2007. Advances in the treatment of Parkinson's disease. Prog Neurobiol 81:29-44.
91. Skuk D, Goulet M, Roy B, Piette V, Côté CH, Chapdelaine P, Hogrel JY, Paradis M, Bouchard JP, Sylvain M, Lachance JG, Tremblay JP. 2007. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul Disord 17:38-46.
92. Stamm C, Friehs I, Choi YH, Zurakowski D, McGowan FX, del Nido PJ. 2003. Cytosolic calcium in the ischemic rabbit heart: Assessment by pH- and temperature-adjusted rhod-2 spectrofluorometry. Cardiovasc Res 59:695-704.
93. Tagliafico E, Brunelli S, Bergamaschi A, De Angelis L, Scardigli R, Galli D, Battini R, Bianco P, Ferrari S, Cossu G, Ferrari S. 2004. TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J Cell Sci 117:4377-4388.
94. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
95. Tamaki T, Okada Y, Uchiyama Y, Tono K, Masuda M, Wada M, Hoshi A, Ishikawa T, Akatsuka A. 2007. Clonal multipotency of skeletal muscle-derived stem cells between mesodermal and ectodermal lineage. Stem Cells 25:2283-2290. (Pubitemid 47480487)
96. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. 1998. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4:1441-1444. (Pubitemid 28553471)
97. Torrente Y, Tremblay JP, Pisati F, Belicchi M, Rossi B, Sironi M, Fortunato F, El Fahime M, D'Angelo MG, Caron NJ, Constantin G, Paulin D, Scarlato G, Bresolin N. 2001. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol 152:335-348. (Pubitemid 34285603)
98. Torrente Y, El Fahime E, Caron NJ, Del Bo R, Belicchi M, Pisati F, Tremblay JP, Bresolin N. 2003a. Tumor necrosis factor-alpha (TNF-alpha) stimulates chemotactic response in mouse myogenic cells. Cell Transplant 12:91-100. (Pubitemid 36397320)
99. Torrente Y, Camirand G, Pisati F, Belicchi M, Rossi B, Colombo F, El Fahime M, Caron NJ, Issekutz AC, Constantin G, Tremblay JP, Bresolin N. 2003b. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol 162:511-520. (Pubitemid 36988559)
100. Torrente Y, Belicchi M, Sampaolesi M, Pisati F, Meregalli M, D'Antona G, Tonlorenzi R, Porretti L, Gavina M, Mamchaoui K, Pellegrino MA, Furling D, Mouly V, Butler-Browne GS, Bottinelli R, Cossu G, Bresolin N. 2004. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114:182-195. (Pubitemid 39071623)
101. Torrente Y, Belicchi M, Marchesi C, Dantona G, Cogiamanian F, Pisati F, Gavina M, Giordano R, Tonlorenzi R, Fagiolari G, Lamperti C, Porretti L, Lopa R, Sampaolesi M, Vicentini L, Grimoldi N, Tiberio F, Songa V, Baratta P, Prelle A, Forzenigo L, Guglieri M, Pansarasa O, Rinaldi C, Mouly V, Butler-Browne GS, Comi GP, Biondetti P, Moggio M, Gaini SM, Stocchetti N, Priori A, D'Angelo MG, Turconi A, Bottinelli R, Cossu G, Rebulla P, Bresolin N. 2007. Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant 16:563-577.
102. Tremblay P, Dietrich S, Mericskay M, Schubert FR, Li Z, Paulin D. 1998. A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev Biol 203:49-61. (Pubitemid 28506662)
103. Uchida N, Fujisaki T, Eaves AC, Eaves CJ. 2001. Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype. J Clin Invest 108:1071-1077. (Pubitemid 32946081)
104. Vetrini F, Tammaro R, Bondanza S, Surace EM, Auricchio A, De Luca M, Ballabio A, Marigo V. 2006. Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides. Hum Mutat 27:420-426. (Pubitemid 43673328)
105. Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R. 2008. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26:916-924.
106. Wognum AW, Eaves AC, Thomas TE. 2003. Identification and isolation of hematopoietic stem cells. Arch Med Res 34:461-475. (Pubitemid 38088007)
107. Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM. 2007. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells. Bioconjug Chem 18:50-60.
108. Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Smith OM, Grubin J, Patel N, Chow A, Cabrera-Perez J, Radhakrishnan R, Diab A, Perales / SNM〉 MA, Rizzuto G, Menet E, Pamer EG, Heller G, Zúñiga-Pflücker JC, Alpdogan O, van den Brink MR. 2006. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med 12:1039-1047.
109. Zeine R, Salwen HR, Peddinti R, Tian Y, Guerrero L, Yang Q, Chlenski A, Cohn SL. 2009. Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.2009. Mod Pathol 22:950-958.
110. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP. 2001. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7:1028-1034. (Pubitemid 32937383)